Home › Neuroblastoma › Wisconsin › Milwaukee
Neuroblastoma clinical trials in Milwaukee, WI
4 studies for Neuroblastoma are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Medical College of Wisconsin, Milwaukee
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Children's Hospital of Wisconsin, Milwaukee
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
RecruitingPhase 1
- Midwest Children's Hospital, Milwaukee
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Children's Hospital of Wisconsin, Milwaukee
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- New York City, NY12 studies
- Washington, DC11 studies
- Dallas, TX10 studies
- Cincinnati, OH9 studies
- St. Louis, MO9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Aurora, CO9 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Harrisburg, PA8 studies
Other studies in Milwaukee
- Cancer (all types)24 studies
- Multiple Myeloma23 studies
- Breast Cancer22 studies
- Non-Small Cell Lung Cancer21 studies
- Lung Cancer21 studies
- Non-Hodgkin Lymphoma19 studies
- Follicular Lymphoma19 studies
- Prostate Cancer19 studies
- Acute Myeloid Leukemia18 studies
- Pancreatic Cancer18 studies
- Ovarian Cancer17 studies
- Diffuse Large B-Cell Lymphoma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.